The trajectory of Sildenafil presents a complex case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, producing billions, the patent end and the subsequent entry of off-brand https://escort693446.csublogs.com/49694188/sildenafil-and-the-pharmaceutical-industry-a-speculative-bet